AppYea invests in sleep monitor

FORT WORTH, Texas – AppYea has acquired SleepX and its flagship product DreamIT, a wearable monitoring solution to treat sleep apnea and snoring. Post-merger, the two companies will focus on the further development and commercialization of SleepX’s solution, including investments in R&D and sales and marketing, as well as an upcoming calibration trial. “I am delighted that we have completed the acquisition of SleepX,” said Boris (Bary) Molchadsky, AppYea’s chairman. “The company develops a wearble technology solution to treat snoring and sleep apnea, which is patent protected in the U.S., E.U. and Israel, and caters to two growing markets in high demand. This acquisition allows us to execute our growth strategy toward the beginning of DreamIT’s marketing during the second half of 2022, while continuing its development with the Biomedical Department at Ben Gurion University in Israel, and launching our first calibration trial. Meanwhile, we are examining the acquisition of other synergetic activities that will complement the SleepX vision to improve sleep quality and quality of life globally.” SleepX will continue to operate under its own brand name as a fully owned subsidiary of AppYea. DreamIT is a patented wristband that communicated with its smartphone app to gently vibrate with every breathing interruption, causing a shift from deep to lighter sleep, training the brain to breath properly, the companies say. The app tracks sleep patterns and, using the company’s machine learning technology, adapts treatment and recommends improvements according to the user’s sleep and breathing patterns.